scPharmaceuticals Inc.
SCPH
|
|
| |
|
| Trading Volume | 7,100 |
|
|
7.68 - 3.72 |
| Market Cap Full | $ 180.7M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.3% | -19.8% | 26.5% | 17.3% |
| Q2 | - | -10.5% | 12.4% | -18.2% |
| Q3 | - | - | -30.1% | 35.3% |
| Q4 | - | -15.9% | -4.4% | 10% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -21.9 | 22.9 | -16.5 | -9 | -14.6 | 11.3 | 15.8 | - | - | - | - | -2.5 |
| 2023 | |||||||||||
| -13.8 | 21.4 | 20.9 | 8.7 | 7.7 | -4.1 | -17.3 | -8.9 | -7.3 | -24.9 | 1.7 | 15.3 |
| 2022 | |||||||||||
| -14.1 | 23.2 | 10.9 | -15.6 | -3.4 | 0.4 | 2.5 | 18.4 | 11.5 | -18.1 | 37.3 | -2.2 |
| 2021 | |||||||||||
| 19.9 | 16.4 | -9.9 | -2.7 | -12.5 | 8 | -9.5 | 13.4 | 4.3 | -10.1 | -26.2 | 15.7 |
| 2020 | |||||||||||
| 10.2 | 50.5 | -18.7 | 27.6 | -11.8 | -11.6 | 1.9 | 15.6 | -14.1 | 13.6 | 9 | -42.6 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -0.3 | -0.3 | -0.4 |
| Q2 | -0.4 | -0.4 | -0.3 | -0.4 |
| Q3 | -0.4 | -0.4 | -0.2 | -0.3 |
| Q4 | 0 | -0.3 | -0.3 | -0.3 |
| A | -1.07 | -1.3 | -1 | -1.3 |